Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?

Hepatology. 2011 Oct;54(4):1118-20. doi: 10.1002/hep.24634.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fatty Liver / mortality*
  • Fatty Liver / pathology*
  • Female
  • Hepatitis C, Chronic / mortality*
  • Hepatitis C, Chronic / pathology*
  • Humans
  • Liver Cirrhosis / mortality*
  • Liver Cirrhosis / pathology*
  • Male
  • Non-alcoholic Fatty Liver Disease